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cell). The SGF will bind to the receptors at
neutral pH and elute from them in weak acid
with the biological activity (induction of
anchorage-independent growth, stimulation
of cell division, specific binding to EGF
receptors) retained. Cells lacking EGF recep-
tors are unable to respond to either EGF or
SGF. The two growth factors differ from one
another in several ways. Antiserum to EGF
does not immunoprecipitate SGF, and anti-
serum to SGF does not immunoprecipitate
mouse EGF. By isoelectric focusing EGF
has a pI of 4 4, while SGF has a pI of 6-8.
They also migrate differently from oneanother
on polyacrylamide gradient gels. Most impor-
tantly, SGF acts in many ways as a "trans-
forming" protein while EGF does not.
Certain human tumour cells have been
found to produce a peptide growth stimulat-
ing factor that is similar in many respects to
SGF. A factor produced by a human rhabdo-
myosarcoma cell line, A673, has been partially
purified. It has an apparent mol. wt of
21,000 and competes with EGF for EGF-
specific membrane receptors. Like mouse
SGF, it induces normal cells, of either rodent
or primate origin, to proliferate in soft agar,
and it also brings about a rapid morphological
transformation ofcells in monolayers. Binding
to and eluting from the EGF receptor-rich
human carcinoma cells, A431, results in
substantial purification of this growth factor.
The exact relationships between human SGF
and mouse SGF remain to be determined.
The possibility is considered that SGF is a
more"c virulent" form of a normal growth-
regulatory protein.
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THE PRODUCTION of a peptide hormone by
a tumour arising in a tissue or organ not
normally associated with that hormone is
now a well established phenomenon in the
biology ofhuman tumours, particularly those
of bronchial origin (Rees & Ratcliffe, 1974).
This apparent phenotypic change accom-
panying the emergence ofa neoplasm presents
an attractive model in which to examine the
relationship between the expression of cell
differentiation and the new acquisition of
specifically neoplastic characteristics.
First it is necessary to establish that a true
heritable change in differentiation has taken
place, not that there is simply a neoplastic
emergence of a small hitherto cryptic popula-
tion of hormone-producing cells. The normal
lung contains populations of cells sharing
ultrastructural (McDowell et al., 1978) and
histochemical (Taylor, 1977) characteristics
with known peptide endocrine cells of the
APUD series, but current evidence has failed
to demonstrate the normal existence of any
of the more commonly tumour-associated
peptide hormones (e.g., ACTH, calcitonin or
vasopressin) in these cells. On the contrary,
tissue-extraction studies have shown a rise in
one ofthese peptides, ACTH, in extracts from
the lungs of a dog subjected to a potentially
carcinogenic stimulus and from a range of
human pathological lung tissues (Yalow,
1979). This suggests that a phenotypic change
can occur in pathological conditions, though
it is not clear which cells of the several types
within the lung are involved.
Evidence on the nature of the hormones
produced by the lung tumours suggests that
they have essentially the same chemical
identity as normal hormones or their pre-
cursors or fragments (e.g., ACTH and related
peptides in a small-cell Ca lung (Bertagna
et al., 1978), although the enzymes respon-
sible for processing the hormones for release
in their "normal" form may be absent or
inappropriate (Lowry et al., 1976). This
suggests that the change which has brought
about the hormone production is an epigenetic
one in which the "normal" gene for the hor-
mone is being expressed in an abnormal or
inappropriate way.
The direct relationship between the pheno-
typic change and the neoplastic initiation is
not yet clear. Evidence from other systems
suggests that carcinogens can effect pheno-BRITISH ASSOCIATION FOR CANCER RESEARCH 665
typic changes (e.g., "intestinal" cell types
appearing in rat liver after 3'-methyl-4-
dimethylaminoazabenzene carcinogenesis
(Yoshida et al., 1978) and muscle cells,
adipocytes and chondrocytes appearing from
fibroblasts (1OT' cell line) after 5-azacytidine
treatment (Taylor & Jones, 1979)). Further
study on the influence of carcinogens on the
lung, particularly with respect to local chan-
ges in hormone production, will be necessary
to determine whether ectopic hormones are
produced as a part of the carcingenic change
or are a consequence of altered cell relation-
ships within the lung.
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THERE HAS LONG been a suspicion that
neoplasia might be in part a disease of
differentiation. The juxtaposition ofthese two
aspects of cellular behaviour is nowhere else
seen so dramatically as in teratocarcinomas,
which are malignant tumours, the stem cells
of which not only proliferate rapidly but also
differentiate into a wide variety of types of
differentiated cell which are themselves
essentially non-malignant. The biology of
these tumours in mice has been elucidated
largely by Stevens (1967). Pierce (1967) and
his collaborators laid the foundations of the
exploration of the cell biology involved. In
subsequent years it has been shown that the
stem cells (embryonal carcinoma cells) may
be established as clonal tissue-culture cell
lines. They will differentiate fully as well
in vitro as in vivo (Martin & Evans, 1975) and
somelineshave beenshown capable ofintegra-
tion with an early mouse embryo and to give
rise to substantial parts of the subsequent
normal mouse (Papaioannou et al., 1978).
The growth and differentiation of terato-
carcinoma cells in vitro is thus established as a
tractable system (Martin, 1975) and explora-
tion of its cell biology and molecular biology
has proceeded on a number offronts. Here the
relationship between embryonal carcinoma
cells and their putative normal counterparts
in the embryo is considered. As terato-
carcinomas may be induced experimentally
by the ectopic implantation ofearly embryos
(up to 7- days old or of germinal ridges con-
taining undifferentiated germ cells) pluri-
potential early embryonic cells or primordial
germ cells would seem to be likely candidates
for the origin of teratocarcinomas. The
expression of cell-surface antigens recognised
by monoclonal antisera, and the major
patterns of protein synthesis seen by two-
dimensional electrophoresis, have been com-
pared for embryonal carcinoma cells and
various embryonic cell types.
These results suggest that choices are made
in cell determination in which only one
daughter line emerges at a time. The stem
line continues in the same state until it
subsequently changes in itself (Evans et al.,
1979). The most likely homologues of
embryonal carcinoma cells are the cells ofthe
inner cell mass ofthe early 5-day embryo.
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